This research aimed to delve into the role of NACC1 and ADAM9 in AML development and found that NACC1 promotes the progression of AML by modulating ADAM9 expression and activating the PI3K/AKT axis. This evidence concerns the gene AKT1 and acute myeloid leukemia.